Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Predict S.P.A. Class B ( (IT:PRE) ) just unveiled an announcement.
Predict S.p.A. has continued its share buyback programme, purchasing 6,000 treasury shares between 16 and 19 December 2025 at a weighted average price of €0.77 per share, for a total outlay of €4,620, bringing its treasury holding to 6,000 shares, or 0.08% of its share capital. The transactions, executed via Integrae SIM under an 18‑month shareholder-approved plan, signal ongoing active capital management by the med‑tech group as it consolidates its market position in innovative diagnostic and digital healthcare technologies, with information on the buyback made available through regulated disclosure channels to keep investors informed.
The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.45 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.
More about Predict S.P.A. Class B
Predict S.p.A., founded in 2008 in Bari, is an Italian med‑tech innovative SME focused on in vivo diagnostics through the distribution of ultrasound and radiology equipment and the development of advanced breath-analysis and digital healthcare technologies. Organised into four strategic business units spanning imaging support, breath analysis and digital healthcare, the company offers solutions such as its Mistral breath-based diagnostic platform, Aphel AI for robotic support in care settings, and Optip holopresence systems, and collaborates with major Italian university hospitals and research institutes while expanding its presence with offices in Bari and Milan.
Average Trading Volume: 22,775
Technical Sentiment Signal: Strong Buy
Current Market Cap: €6.3M
See more insights into PRE stock on TipRanks’ Stock Analysis page.